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Abstract
Background: Inappropriate prescribing of antimicrobials is a significant threat to global public health. In England,
approximately 5% of all antimicrobial items are prescribed by dentists, despite the limited indications for their use
in the treatment of oral infections in published clinical guidelines. The objective of this study was to survey
antimicrobial prescribing by dental practitioners in North East England and Cumbria, identify educational and
training needs and develop a self-assessment tool that can be used for Continued Professional Development by
individual practitioners.
Methods: During October 2016, 275 dental practitioners used a standardised form to record anonymous
information about patients who had been prescribed antimicrobials. Clinical information and prescribing details
were compared against clinical guidelines published by the Faculty of General Dental Practitioners UK.
Results: Dental practitioners provided data on 1893 antimicrobial prescriptions. There was documented evidence of
systemic spread, such as pyrexia in 18% of patients. Dentists recorded patients’ pain (91.1% of patients), local lymph
gland involvement (41.5%) gross diffuse swelling (55.5%) dysphagia (7.2%) and trismus (13.6%). Reasons for
prescribing antimicrobials included patient expectations (25.8%), patient preference (24.8%), time pressures (10.9%),
and patients uncooperative with other treatments (10.4%). The most commonly prescribed antimicrobials were
amoxicillin, accounting for 61.2% of prescriptions, followed by metronidazole (29.9%). Most prescriptions for
amoxicillin were for either 5 days (66.8%) or 7 days (29.6%) and most prescriptions for metronidazole were for a 5-
day course (65.2%) or 7-day (18.6%) course.
Conclusion: In most cases, when an antimicrobial was prescribed, practitioners used the correct choice of agents
and usually prescribed these at the correct dose. However, some evidence of suboptimal prescribing practices
when compared to the Faculty of General Dental Practitioner guidelines were identified. The audit has identified
training needs across the region and aided the development of Continued Professional Development sessions.
Further work to identify barriers and facilitators for improving antimicrobial prescribing and determining
appropriate methods to improve clinical practice are required.
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Background
Antimicrobial resistance is a significant threat to global
public health. The World Health Organisation has
stressed the seriousness of this problem and their Global
Report of Surveillance in 2014 (p. IX) concluded that ‘A
post-antimicrobial-era in which common infections and
minor injuries can kill – is a very real possibility for the
21st century’ [1].
Antimicrobial stewardship is defined by the UK Na-
tional Institute for Health and Care Excellence (NICE)
as ‘an organisational or healthcare-system-wide approach
to promoting and monitoring judicious use of antimicro-
bials to preserve their future effectiveness’ [2]. Therefore
commissioners, providers and individual practitioners
should embrace antimicrobial stewardship with the view
to improving practice [2]. When prescribing antimicro-
bials, prescribers should follow local antimicrobial guide-
lines, where available, or national guidelines, such as the
UK Faculty of General Dental Practitioners (FGDP)
guidelines on prescribing the shortest effective course,
the most appropriate dose and the route of administra-
tion for appropriate clinical indications [3].
The FGDP antimicrobial prescribing guidelines for
general dental practitioners recommends that antimicro-
bials are only indicated for the following [3]:
 As an adjunct to the management of acute or
chronic infection
 For the definitive management of active infective
disease such as necrotising ulcerative gingivitis
 Where definitive treatment has to be delayed due to
referral to a specialist service, examples include
inability to establish drainage in an uncooperative
patient who requires sedation or general anaesthesia
for treatment, or a patient who needs to be treated
in a hospital environment due to comorbidities.
Antibiotic consumption has increased by 6.5% over
the past 4 years in England [4]. Prescribing is measured
as the defined daily dose (DDD) of antimicrobials taken
by an individual per 1000 inhabitants per day. Prescrib-
ing increased from 21.6 DDD per 1000 inhabitants per
day in England in 2011 to 23 DDD per 1000 inhabitants
per day in 2014 [4]. In 2014, the majority (66.6%) of den-
tal prescriptions were used to treat infections and al-
though dental prescribing accounts for only 0.5% of all
items prescribed in England [4], dentists are responsible
for 5% of all antimicrobial drug prescriptions [5]. The
highest combined general practice, hospital and dentist
usage in England in 2015 at 27.4 DDD per 1000 inhabi-
tants per day was Merseyside. Antibiotic prescribing is
also high in the North East of England, with the second
highest DDD nationally (25.8) in Cumbria, Northumber-
land and Tyne & Wear and the third highest (25.3) in
Durham, Darlington and Tees [5]. Antibiotic consump-
tion was 26.5% higher in Cumbria, Northumberland and
Tyne and Wear than in Leicestershire and Lincolnshire
which had the lowest usage of antimicrobials at 20.4
DDD per 1000 inhabitants per day [5]. The potential
reasons for the variations in regional prescribing prac-
tices are unclear, this may be due to socioeconomic fac-
tors, although studies have found that this can only
partly explain differences in antimicrobial use [6].
Clinical audit can provide practitioners with a way of
assessing their compliance with current prescribing guide-
lines and there is evidence that antimicrobial prescribing
can be improved following clinical audit, leading to a re-
duction in inappropriate prescribing and prescribing er-
rors [7–9]. A recent audit of dental antimicrobial
prescribing in Wales provides a benchmark for assessing
prescribing in the North East and Cumbria. The authors
found that 21.8% of antimicrobial prescriptions did not
meet the dose, frequency or duration advised in clinical
guidelines [9]. The specific prescribing choices for each in-
dication were not reported; therefore our study has been
designed to further explore the antimicrobial choices for
each clinical diagnosis and present detailed prescribing in-
formation to further support the literature in this field.
The aim of this study was to produce data on anti-
microbial prescribing by dental practitioners in the
North East of England and Cumbria.
Methods
Design
The study was designed to capture prospective data on anti-
microbial prescribing by dental practitioners in the North
East and Cumbria during the month of October 2016. Den-
tists were asked to record information on the next 10 con-
secutive antimicrobial prescriptions they gave to patients
from the start of the census period. The purpose of the audit
tool was to capture the prescribing practices of participants
and not the frequency of prescribing The standard used in
the audit was the Faculty of General Dental Practitioners
antimicrobial guidelines [3]. Comparative data for dental pre-
scriptions dispensed by pharmacies in the North East of Eng-
land and Cumbria during the month of the audit were also
provided by the NHS Business Service Authority (BSA).
Population
The population consisted of all dentists (2318) on the
National Health Service (NHS) performer list working
under NHS contracts in the North East and Cumbria.
Participants were identified via NHS England, who
posted all study materials to the registered address of
providers with a general dental services or community
dental services contract in the North East and Cumbria.
A reminder letter was sent half way through the audit
period.
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Audit tool
The audit tool (see Additional file 1) consisted of two
parts. The first section captured demographic informa-
tion of participating dental practitioners. This informa-
tion included gender, age, country of undergraduate
study and area of current practice. Information regard-
ing the size of their practice, Dental Foundation Train-
ing or General Professional Training practice status and
the number of patients typically seen per day was also
obtained. The audit tool was piloted in two practices be-
fore being finalised.
The second section of the audit tool captured informa-
tion on 10 antimicrobial prescriptions. Participants were
asked to record information on the next 10 consecutive
antimicrobial prescriptions they gave to patients; if par-
ticipants did not prescribe antimicrobials to 10 patients
during the audit period (October 2016), they were asked
to return the audit tool with the data from the patients
for whom they did prescribe.
The following information was recorded for each anti-
microbial prescription:
 Patient information – age and allergy status
 Diagnosis and features – clinical diagnosis and
presenting features, such as pyrexia, pain, local
lymph gland involvement, diffuse swelling,
dysphagia, trismus
 Antibiotic prescribed – name, dose, quantity,
frequency, duration
 Influencing factors – patient expectations,
preferences, time pressures, patients condition,
uncertain diagnosis, failure of anaesthesia,
uncooperative patients and failure of other
treatments
Procedure
The audit tool was posted by NHS England to dental
practices in the North East and Cumbria during Septem-
ber 2016. A covering letter was included, explaining the
background and purpose of the audit, the letter ex-
plained that the audit was voluntary, but would provide
participants with 3 h of Continued Professional Develop-
ment (CPD) for completing and returning the audit. A
reminder letter was sent to all providers 2 weeks into the
audit period.
Ethics
The project was approved by the University of Sunder-
land Research Ethics Committee.
Analysis
Completed audit templates were returned to the Univer-
sity of Sunderland for data entry and analysis using
SPSS.
Results
Based on data received from NHS England, there are an
estimated 2318 performers in the North East and Cum-
bria. A total of 275 dental practitioners returned data on
the audit, with a response rate of 11.9%. Practitioners
provided data on 1893 antimicrobial prescriptions.
Participant demographics
Of the 275 participants, 56% were male and 37.1% fe-
male; the remainder did not state their gender. The vast
majority (81.8%) of participants had undertaken their
undergraduate dental training in the UK, with the
remaining studying in Europe (7.3%), and outside of Eur-
ope (4%); 6.9% of participants did not provide informa-
tion on where they studied. Most participants described
themselves as general dental practitioners (88.4%) with
several orthodontists (2.2%) and community dentists
(0.7%), also participating. The area of practice was miss-
ing from 8% of audit returns.
The largest proportion of responses came from Tyne
and Wear with 35.6%, with Northumbria (10.2%), show-
ing the smallest return. These returns are broadly as ex-
pected given the relative sizes of the populations of each
of these areas. Data were missing from 6.9% of partici-
pants and the region was uncertain from the responses
in 0.7% of participants.
Participants were asked to provide information on the
practice in which they worked, 32.2% stated they worked
in a Vocational Training (VT) or General Professional
Training (GPT) practice; both VT and GPT practices are
approved sites for the post-qualification training period re-
quired for UK graduates in order to work in NHS practice
[10]. The modal number of practitioners working at a
practice was 3 (range 1–23). The majority of participants,
62.5%, reported that they saw 21–30 patients per day.
Antibiotic prescribing
Data on a total of 1893 antimicrobial prescriptions were
reported in the audit. The mean age of patients who
were prescribed antimicrobials was 43.02 years (SD
19.67 years); patients’ ages ranged from 1 to 91 years.
Allergy information was recorded for the majority of pa-
tients (see Table 1); this information was missing for 92 pa-
tients. Most patients (85.1%) did not have a known
antimicrobial allergy; the most frequent antimicrobial allergy
reported by patients was for amoxicillin, for 7.3% of patients.
Antibiotics were prescribed for a range of indications.
The most common indication was an acute
dento-alveolar infection (43.2% of prescriptions),
followed by pericoronitis (14.7%) and periodontal ab-
scess (11.7%). The indication was described as ‘other’ in
3% of prescriptions with no further description given. In-
dication was missing from the remaining 2.9% of pre-
scriptions (see Table 2).
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There was documented evidence of systemic spread,
such as pyrexia in 18% of patients. Pain was reported in
91.1% of patients. Local lymph gland involvement was
evident in 41.5% of prescriptions, with gross diffuse
swelling present in 55.5% of cases. Dysphagia and tris-
mus was present in 7.2 and 13.6% of patients
respectively.
The most commonly prescribed antimicrobials were
amoxicillin, accounting for 61.2% of prescriptions,
followed by metronidazole (29.9%). The vast majority of
patients were prescribed only one antimicrobial. Where
multiple antimicrobials were prescribed, the most fre-
quent combination was amoxicillin and metronidazole
(1.7%). The frequency of each antimicrobial prescribed is
shown in Table 3.
Data for dental prescriptions dispensed by pharmacies
in the North East of England and Cumbria during the
month of the audit was provided by the NHS Business
Service Authority (BSA) (Additional file 2). The number
of prescriptions issued for each antimicrobial is shown
in Table 4. The frequency of prescriptions for each anti-
microbial closely matches the data from this audit.
Amoxicillin
Amoxicillin was typically prescribed at a dose of 500 mg
(78.5%) or 250 mg (16.8%) and usually three times daily
(98.3%). Most prescriptions for amoxicillin were for ei-
ther 5 days (66.8%) or 7 days (29.6%) duration; the mean
duration was 5.61 days (SD 1.06 days).
Metronidazole
Metronidazole was the second most frequent antimicro-
bial prescribed, with doses of 400mg accounting for
53.8% and 200 mg, 42.6% of cases. Almost all (98.1%) of
prescriptions were for three times daily dosing and the
mean duration of course was 5.13 days (SD 1.14). Most
prescriptions were for a 5-day course (65.2%), 7-day
(18.6%) or 3-day (12.9%) course.
Erythromycin
Erythromycin was the third most prescribed antimicro-
bial identified in the audit (2.8%), when prescribed it was
usually given at a dose of 250mg (60.4%) or 500 mg
(32.1%). It was prescribed 3 times daily in 22.6% or 4
times daily in 75.5% of cases. Erythromycin was pre-
scribed for a mean duration of 5.49 days (SD 1.01).
Table 1 Frequency of documented antibiotic allergies
Antibiotic Frequency Percent
Amoxicillin 135 7.1
Metronidazole 19 1
Phenoxymethylpenicillin 10 0.5
Erythromycin 6 0.3
Amoxicillin and Phenoxymethylpenicillin 3 0.2
Cefalexin 3 0.2
Amoxicillin and Erythromycin 2 0.1
Amoxicillin and Metronidazole 2 0.1
Amoxicillin and Ampicillin 2 0.1
Amoxicillin, Ampicillin, Phenoxymethylpenicillin 2 0.1
Ampicillin 2 0.1
Amoxicillin, Ampicillin, Phenoxymethylpenicillin,
Co-amoxiclav
1 0.1
Phenoxymethylpenicillin and Metronidazole 1 0.1
Azithromycin 1 0.1
Clindamycin 1 0.1
No known antibiotic allergy 1611 85.1
No information provided 92 4.9
Total 1893 100
Table 2 Frequency of reported clinical diagnosis
Clinical Diagnosis Frequency Percent
Acute dento-alveolar infection 817 43.2
Pericoronitis 279 14.7
Periodontal abscess 221 11.7
Dry socket 145 7.7
Chronic dento-alveolar infection 130 6.9
Acute Dental Pain/Pulpitis 62 3.3
Necrotising ulcerative gingivitis 58 3.1
Other 57 3
Prophylactic antibiotics 25 1.3
Acute sinusitis 13 0.7
Gingivitis 12 0.6
Acute dento-alveolar infection and Acute
Dental Pain/Pulpitis
2 0.1
Acute dento-alveolar infection and Chronic
dento-alveolar infection
2 0.1
Acute dento-alveolar infection and
Periodontal abscess
2 0.1
Acute dento-alveolar infection and Dry socket 2 0.1
Periodontal abscess and Necrotising
ulcerative gingivitis
2 0.1
Acute dento-alveolar infection and Gingivitis 1 0.1
Acute dento-alveolar infection and Acute sinusitis 1 0.1
Necrotising ulcerative gingivitis and Dry socket 1 0.1
Pericoronitis and others 1 0.1
Local anaesthetic complication 1 0.1
Stomatitis 1 0.1
Tonsillitis 1 0.1
Trauma 1 0.1
No information provided 56 3
Total 1893 100
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Reasons for prescribing antimicrobials
The reasons for prescribing an antimicrobial was docu-
mented for 91.9% of patients (participants could docu-
ment more than one reason if appropriate). Data were
missing for 8.1% of patients. Table 5 illustrates the rea-
sons for prescribing and the frequency of responses. The
patient’s condition was the most frequent reason given
for prescribing an antimicrobial and was a documented
factor in 90.4% of cases. This was followed by patient ex-
pectations and patient preference, 25.8 and 24.8% of
cases respectively. Time pressure (10.9%), and patients
uncooperative with other treatment (10.4%), were also
reported by participants.
Acute dento-alveolar infections
According to the FGDP guidelines, the first choice treat-
ment for this indication is amoxicillin which should be
prescribed for adults and children over the age of 6 years
at a dose of 500 mg 3 times daily for up to 5 days. We
found that amoxicillin was the most frequently pre-
scribed antimicrobial and that the duration of treatment
was in most cases 5 days (68%), although a number of
prescriptions (28.6%) were for 7 days treatment. A lower
dose of 250 mg was prescribed in 13.9% of cases. Sys-
temic spread, such a pyrexia (18%) or local lymph glad
involvement (41.5%), were not always present when pre-
scribing antimicrobials.
Metronidazole is the second choice agent for this indi-
cation and in patients over 10 years of age should be
prescribed at a dose of 400 mg three times daily for up
to 5 days. The duration of prescribing matched the
guidelines in 68.5% of cases, but prescriptions for 7 days
duration (20.7%) were relatively frequent.
Periodontal abscess
Treatment recommendations for a periodontal abscess
are the same as those for an acute dento-alveolar infec-
tion. The most frequently prescribed antimicrobial for
this indication was amoxicillin, typically prescribed for 5
days (61.5%) duration, or 7 days, (37.6%). Where metro-
nidazole was prescribed, it was usually for 5 days
(68.5%), or 7 days (20.7%). In 10% of cases amoxicillin
was prescribed at a lower dose of 250 mg.
Table 3 Frequency of each antimicrobial prescribed
Antibiotic Frequency Percent
Amoxicillin 1159 61.2
Metronidazole 566 29.9
Erythromycin 53 2.8
Amoxicillin and Metronidazole 33 1.7
Cefalexin 8 0.4
Clarithromycin 7 0.4
Clindamycin 5 0.3
Co-amoxiclav 5 0.3
Other (specify) 4 0.2
Phenoxymethylpenicillin 3 0.2
Ampicillin 2 0.1
Cefradine 2 0.1
Doxycycline 2 0.1
Azithromycin 1 0.1
Clindamycin and Metronidazole 1 0.1
Co-amoxiclav and Metronidazole 1 0.1
No information provided 41 2.2
Total 1893 100
Table 4 The number of dental antibiotic prescriptions issued by
pharmacies in the North East of England and Cumbria (NHS BSA
prescribing data October 2016)
Antibiotic Number of
Prescriptions
Percent of
prescriptions
Amoxicillin 9336 68.82
Metronidazole 3631 26.77
Erythromycin 420 3.10
Phenoxymethylpenicillin 44 0.32
Co-amoxiclav 33 0.24
Clarithromycin 30 0.22
Clindamycin 23 0.17
Cefalexin 21 0.15
Doxycycline 14 0.10
Tetracycline 8 0.06
Oxytetracycline 3 0.02
Azithromycin 2 0.01
Total 13,565 100.00
Table 5 Reported reason for issuing antimicrobial prescription
Reason for prescribing Responses Percent
of CasesNumber Percent
Patient’s condition 1572 50.8% 90.4%
Patient expectations 448 14.5% 25.8%
Patient preference 432 13.9% 24.8%
Time pressures 190 6.1% 10.9%
Patient uncooperative with
other treatment
181 5.8% 10.4%
Unclear/uncertain diagnosis 116 3.7% 6.7%
Failure of other treatment 111 3.6% 6.4%
Failure of anaesthesia 47 1.5% 2.7%
Total 3097 100% 178 .1%
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Pericoronitis
FGDP guidelines recommend that treatment of pericoro-
nitis should follow local measures unless patients present
with pyrexia, spreading infection, persistent swelling or
trismus. Where an antimicrobial is recommended, metro-
nidazole should be the first choice, at a dose of 400mg
three times daily (patients aged over 10 years) for up to 5
days. The most frequently prescribed antimicrobial for the
treatment of pericoronitis was metronidazole, typically
prescribed for 5 days, (69.8%) duration or 3 days (16.4%).
Where amoxicillin was prescribed, it was usually for 5
days (61.8%) or 7 days (35.5%) duration.
Chronic dento-alveolar infection
Where antimicrobial treatment is required the treatment
should follow the guidance for the treatment of acute
dento-alveolar infections. The most frequently prescribed
antimicrobial for the treatment of a chronic dento-alveolar
infection was amoxicillin, typically prescribed for 5 days
duration (66.3%), or 7 days (30.5%), a lower dose of 250mg
of amoxicillin recorded on 16.7% of prescriptions. Where
metronidazole was prescribed, it was usually for 5 days
(60.9%) or 7 days, (34.8%) duration.
Dry socket
The management of dry socket involves local measures;
with antimicrobials not routinely recommended. Practi-
tioners reported prescribing for this indication with 7.7%
of all prescriptions recorded for this indication. The
most frequently prescribed antimicrobial for the treat-
ment of a dry socket was metronidazole, typically pre-
scribed for 5 days duration (59.4%) or 7 days (24.6%).
Where amoxicillin was prescribed, it was usually for 5
days (76.2%) or 7 days (20.6%) duration.
Discussion
This antimicrobial audit has provided prospective data
on the prescribing of antimicrobials by 275 dentists in
the North East of England and Cumbria. The majority of
the respondents were general dental practitioners and
trained in the UK.
Amoxicillin was the most frequently prescribed anti-
microbial, followed by metronidazole and then erythro-
mycin. This pattern of prescribing is confirmed by the
NHS Business Services Authority prescription data, the
antimicrobial prescriptions dispensed by community
pharmacies during October 2016 closely matches those
reported in this audit [11]. Antibiotics such as
co-amoxiclav, cephalosporins, clindamycin and quino-
lones, which do not appear on FGCP guidelines were
prescribed infrequently, by participants in this audit.
The most common indication for antimicrobial pre-
scribing was for the treatment of an acute dento-alveolar
infection. Other common indications included
pericoronitis, periodontal abscess, dry socket and chronic
dento-alveolar infections. For conditions such as dry
socket, routine use of antimicrobials is not recommended
and therefore indicates a potential need for further educa-
tion of practitioners.
For the treatment of acute-dento alveolar infections
FGDP guidelines recommend that antimicrobials should
only be prescribed as adjuncts to treatment and there
should be evidence of systemic spread, pyrexia and local
lymph gland involvement [3]. Results from this audit
suggest that evidence of systemic spread, such a pyrexia
or local lymph glad involvement were frequently absent
when prescribing antimicrobials. This finding is similar
to a recent study performed in Wales, where only 37.2%
of patients prescribed antimicrobials had signs of spread-
ing infection or systemic involvement [9].
The patient’s condition was the key determining factor in
practitioners prescribing antimicrobials; however, patient
expectations were also frequent considerations in treatment
choice. Work has been carried out in primary care medical
practices to help educate patients about the unnecessary
use of antimicrobials and there is evidence that public cam-
paigns can potentially contribute to more careful use of an-
timicrobials [12]; this could be seen as a tool for reducing
expectations in relation to dental prescribing.
Other reasons such as patient preference, time pressure
and a lack of co-operation with other treatment options
by patients were also commonly reported; these findings
are similar to those from a recent study in Wales [13].
These are considerations for prescribers and further work
to explore these factors using qualitative methods, would
be beneficial in gaining a deeper appreciation of the rea-
sons why practitioners prescribe antimicrobials, as well as
what informs their choice of antimicrobial.
Following competition of the audit the dental anti-
microbial stewardship (AMS) toolkit was published
[5], by the Dental Subgroup of Public Health
England’s English surveillance programme for anti-
microbial utilisation and resistance (ESPAUR), FGDP
and British Dental Association (BDA). The toolkit
produced provided an audit tool for antimicrobial
prescribing and patient focused information such as
information leaflets and posters [14].
Limitations
The audit was voluntary and reflected in the low response
rate, therefore, those participating may be the practi-
tioners who are most engaged in CPD and prescribing
education. Therefore, those practitioners who were less
likely to be up to date with current prescribing trends,
were less likely to have been captured during this process.
The audit was based on self-reports of the assessment of
patient presentations and symptoms and also required
dental practitioners to record data on antimicrobials that
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they prescribed over the audit period, rather than report-
ing retrospective data, as such the potential for practi-
tioners to alter their prescribing habits (or checking the
guidelines) needs to be taken into consideration.
Recommendations
Based on our results, we make several
recommendations:
 Health Education England and the Local Dental
Networks should highlight current guidance in
relation to the local management of dental infections
to practitioners, such as mail out of FGDP guidance
to practices.
 Educational opportunities for practitioners, focusing
on the recommended indications, duration of
therapy and doses for antimicrobial prescriptions
should be explored, for example, dissemination of
guidance or CPD sessions.
 Opportunities to educate patients on antimicrobial use
in dentistry should be reviewed. The posters produced
as part of the AMS toolkit and patient information
leaflet should be displayed in dental practices.
 Further research building on the existing literature
exploring the underlying factors that lead to the
prescribing of antimicrobials by dental practitioners
should be considered. This could be achieved
through qualitative research, utilising interviews or
focus groups with dental practitioners.
Conclusion
This antimicrobial audit has shown that in most cases,
when an antimicrobial is prescribed, practitioners are
using the correct choice of agents and usually prescrib-
ing these at the correct dose. However, we did find some
evidence of suboptimal prescribing practices which indi-
cate that there may be a need for further support and/or
training for prescribers. Underlying reasons for anti-
microbial prescribing have been identified, but a deeper
understanding is required to explore this fully and iden-
tify barriers or facilitators to improve clinical practice.
The audit has identified training needs across the region
and the development of CPD sessions on appropriate
prescribing. The ESPAUR toolkit published subsequently
to our audit provides an audit tool for practitioners.
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